​

Nutrien (NTR) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NTR Stock Forecast

Nutrien stock forecast is as follows: an average price target of $57.71 (represents a 29.45% upside from NTR’s last price of $44.58) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.

NTR Price Target

The average price target for Nutrien (NTR) is $57.71 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $75.00 to $50.00. This represents a potential 29.45% upside from NTR's last price of $44.58.

NTR Analyst Ratings

Buy

According to 18 Wall Street analysts, Nutrien's rating consensus is 'Buy'. The analyst rating breakdown for NTR stock is 0 'Strong Buy' (0.00%), 9 'Buy' (50.00%), 7 'Hold' (38.89%), 2 'Sell' (11.11%), and 0 'Strong Sell' (0.00%).

Nutrien Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 18, 2024Charles NeivertPiper Sandler$50.00$45.489.94%12.16%
Sep 24, 2024Richard GarchitorenaWells Fargo$50.00$47.485.31%12.16%
Sep 10, 2024Adam SamuelsonGoldman Sachs$53.00$46.0914.99%18.89%
Aug 09, 2024Jacob BoutCIBC$64.00$45.8739.52%43.56%
Aug 09, 2024Joel JacksonBMO Capital$75.00$45.7563.95%68.24%
Aug 08, 2024Edlain RodriguezMizuho Securities$52.00$47.0810.45%16.64%
Jul 15, 2024Andrew WongRBC Capital$60.00$49.6820.77%34.59%
Jun 13, 2024Joel JacksonBMO Capital$80.00$51.1756.34%79.45%
Jun 12, 2024John RobertsUBS$67.00$52.4227.81%50.29%
May 17, 2024Charles NeivertPiper Sandler$56.00$57.48-2.57%25.62%
May 13, 2024Vincent AndersonStifel Nicolaus$69.00$57.3020.42%54.78%
May 13, 2024Ben IsaacsonScotiabank$66.00$57.3915.00%48.05%
May 09, 2024Edlain RodriguezMizuho Securities$59.00$55.436.44%32.35%
Apr 29, 2024Aron CeccarelliBerenberg Bank$66.00$54.1321.93%48.05%
Apr 08, 2024Vincent AndersonStifel Nicolaus$73.00$56.1230.08%63.75%
Mar 26, 2024Laurence AlexanderJefferies$62.00$52.5517.98%39.08%
Jan 11, 2023UBS$103.00$74.2438.74%131.05%
Jan 11, 2023Morgan Stanley$91.00$73.8923.16%104.13%
Nov 30, 2022Piper Sandler$93.00$81.6413.91%108.61%
Nov 17, 2022Barclays$95.00$77.7322.22%113.10%
Apr 29, 2022Mizuho Securities$124.00$98.2526.21%178.15%
Apr 21, 2022RBC Capital$135.00$113.1219.34%202.83%
Mar 30, 2022NutrienCitigroup$126.00$102.0623.46%182.64%
Mar 08, 2022Charles NeivertPiper Sandler$112.00$94.8118.13%151.23%
Mar 01, 2022Vincent AndersonStifel Nicolaus$100.00$84.5318.30%124.32%
Feb 27, 2022Andrew StottUBS$94.00$85.589.84%110.86%
Feb 18, 2022Colin IsaacAtlantic Equities$79.00$75.424.75%77.21%
Feb 18, 2022Chris ParkinsonMizuho Securities$94.00$75.4224.64%110.86%
Feb 18, 2022Steve HansenRaymond James$96.29$75.4227.67%115.98%
Feb 18, 2022Duffy FischerBarclays$92.00$75.4221.98%106.37%
Aug 20, 2021Santhosh SeshadriHSBC$73.00$58.2825.26%63.75%
Aug 11, 2021Steve ByrneBank of America Securities$80.00$62.5127.98%79.45%
Jun 29, 2021Sandy KlugmanSusquehanna$70.00$58.2720.13%57.02%

The latest Nutrien stock forecast, released on Nov 18, 2024 by Charles Neivert from Piper Sandler, set a price target of $50.00, which represents a 9.94% increase from the stock price at the time of the forecast ($45.48), and a 12.16% increase from NTR last price ($44.58).

Nutrien Price Target by Period

1M3M12M
# Anlaysts1216
Avg Price Target$50.00$50.00$62.63
Last Closing Price$44.58$44.58$44.58
Upside/Downside12.16%12.16%40.49%

In the current month, the average price target of Nutrien stock is $50.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 12.16% increase as opposed to Nutrien's last price of $44.58. This month's average price target is down 0.00% compared to last quarter, and down -20.17% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 11, 2024OppenheimerOutperformInitialise
Nov 18, 2024Piper SandlerUnderweightUnderweightHold
Oct 15, 2024JefferiesBuyBuyHold
Sep 24, 2024Wells FargoOverweightEqual-WeightDowngrade
Sep 10, 2024Goldman SachsNeutralDowngrade
Aug 09, 2024CIBCOutperformOutperformHold
Aug 09, 2024BMO CapitalOutperformOutperformHold
Aug 01, 2024HSBCHoldReduceDowngrade
Jul 15, 2024RBC CapitalOutperformOutperformHold
Jun 13, 2024ScotiabankSector OutperformSector OutperformHold
Jun 13, 2024BMO CapitalOutperformOutperformHold
Jun 12, 2024UBSBuyBuyHold
May 17, 2024Piper SandlerUnderweightUnderweightHold
May 13, 2024ScotiabankOutperformOutperformHold
Mar 26, 2024JefferiesBuyInitialise
Jul 31, 2023TD SecuritiesBuyUpgrade
Jul 24, 2023UBSBuyNeutralDowngrade
Jul 24, 2023Wells FargoEqual-WeightDowngrade
Jul 24, 2023Argus ResearchHoldDowngrade
Jul 24, 2023William BlairMarket PerformInitialise
May 12, 2023Credit SuisseUnderperformUnderperformHold
May 12, 2023RBC CapitalOutperformOutperformHold
May 12, 2023BarclaysOverweightOverweightHold
May 12, 2023Raymond JamesMarket PerformOutperformUpgrade
Feb 21, 2023HSBCHoldHoldHold
Feb 03, 2023Raymond JamesMarket PerformDowngrade
Jan 11, 2023UBSBuyBuyHold
Jan 11, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Nov 30, 2022Piper SandlerOverweightNeutralDowngrade
Nov 17, 2022BarclaysOverweightOverweightHold
Aug 09, 2022ScotiabankSector OutperformUpgrade
Jun 09, 2022Mizuho SecuritiesNeutralNeutralHold
Mar 08, 2022Piper SandlerOverweightUpgrade
Feb 22, 2022RBC CapitalOutperformOutperformHold
Feb 18, 2022BarclaysOverweightOverweightHold
Feb 18, 2022Atlantic EquitiesNeutralUpgrade

Nutrien's last stock rating was published by Oppenheimer on Dec 11, 2024. The company Initialise its NTR rating from "null" to "Outperform".

Nutrien Financial Forecast

Nutrien Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$5.82B--$6.11B$7.53B$8.19B$14.51B$7.66B$7.27B$6.02B$9.76B$4.66B$4.10B$4.21B$8.42B$4.19B$3.54B$4.13B
Avg Forecast$5.23B$4.98B$9.80B$5.04B$5.34B$5.25B$10.08B$5.14B$5.03B$5.33B$10.82B$5.29B$5.49B$5.72B$11.06B$6.36B$7.41B$8.53B$14.68B$7.65B$6.47B$5.41B$9.66B$4.44B$3.56B$3.76B$8.34B$3.54B$3.48B$4.04B
High Forecast$5.40B$5.15B$10.13B$5.21B$5.52B$5.42B$10.42B$5.15B$5.28B$5.51B$11.18B$5.46B$5.72B$6.21B$11.43B$6.57B$7.65B$8.53B$14.68B$7.65B$6.47B$5.41B$9.66B$4.44B$3.56B$3.76B$8.34B$3.54B$3.48B$4.04B
Low Forecast$5.01B$4.77B$9.39B$4.83B$5.11B$5.03B$9.66B$5.12B$4.83B$5.11B$10.36B$5.07B$5.26B$5.39B$10.60B$6.09B$7.09B$8.53B$14.68B$7.65B$6.47B$5.41B$9.66B$4.44B$3.56B$3.76B$8.34B$3.54B$3.48B$4.04B
# Analysts1111111363336105548889999999955
Surprise %------------1.06%--0.96%1.02%0.96%0.99%1.00%1.12%1.11%1.01%1.05%1.15%1.12%1.01%1.18%1.02%1.02%

Nutrien's average Quarter revenue forecast for Mar 24 based on 3 analysts is $5.29B, with a low forecast of $5.07B, and a high forecast of $5.46B. NTR's average Quarter revenue forecast represents a -9.14% decrease compared to the company's last Quarter revenue of $5.82B (Dec 23).

Nutrien EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111363336105548889999999955
EBITDA------------$1.27B--$1.42B$2.15B$2.43B$5.06B$2.48B$2.19B$1.54B$2.10B$752.00M$870.00M$-222.00M$1.66B$555.00M$450.00M$785.00M
Avg Forecast$1.10B$1.05B$2.06B$1.06B$1.12B$1.10B$2.12B$1.08B$1.06B$1.12B$2.28B$3.00B$1.15B$1.20B$2.33B$2.73B$2.01B$1.95B$3.36B$2.48B$1.48B$1.24B$2.21B$919.11M$813.44M$859.28M$1.91B$244.20M$795.12M$923.90M
High Forecast$1.14B$1.08B$2.13B$1.10B$1.16B$1.14B$2.19B$1.08B$1.11B$1.16B$2.35B$3.60B$1.20B$1.31B$2.40B$3.27B$2.41B$1.95B$3.36B$2.98B$1.48B$1.24B$2.21B$1.10B$813.44M$859.28M$1.91B$293.04M$795.12M$923.90M
Low Forecast$1.05B$1.00B$1.98B$1.02B$1.08B$1.06B$2.03B$1.08B$1.02B$1.07B$2.18B$2.40B$1.11B$1.13B$2.23B$2.18B$1.61B$1.95B$3.36B$1.98B$1.48B$1.24B$2.21B$735.29M$813.44M$859.28M$1.91B$195.36M$795.12M$923.90M
Surprise %------------1.10%--0.52%1.07%1.25%1.51%1.00%1.48%1.24%0.95%0.82%1.07%-0.26%0.87%2.27%0.57%0.85%

3 analysts predict NTR's average Quarter EBITDA for Mar 24 to be $3.00B, with a high of $3.60B and a low of $2.40B. This is 135.68% upper than Nutrien's previous annual EBITDA (Dec 23) of $1.27B.

Nutrien Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111363336105548889999999955
Net Income------------$172.00M--$571.00M$1.11B$1.58B$3.59B$1.38B$1.21B$717.00M$1.11B$127.00M$316.00M$-587.00M$765.00M$-35.00M$-48.00M$141.00M
Avg Forecast$231.77M$177.77M$1.02B$220.62M$320.70M$265.92M$1.07B$168.40M$180.63M$228.66M$1.08B$1.69B$318.67M$303.93M$1.37B$1.53B$1.04B$1.91B$2.83B$1.39B$1.18B$602.32M$1.04B$155.22M$86.51M$58.25M$656.59M$-15.40M$120.41M$197.62M
High Forecast$241.78M$185.44M$1.06B$230.14M$334.55M$277.41M$1.11B$179.26M$232.24M$238.54M$1.09B$2.02B$442.60M$442.49M$1.43B$1.84B$1.25B$1.91B$2.83B$1.67B$1.18B$609.32M$1.04B$186.27M$86.51M$58.25M$656.59M$-12.32M$120.41M$197.62M
Low Forecast$219.12M$168.06M$964.13M$208.58M$303.19M$251.41M$1.01B$157.54M$134.18M$216.18M$1.08B$1.35B$212.45M$219.01M$1.29B$1.23B$831.95M$1.91B$2.83B$1.11B$1.18B$595.31M$1.04B$124.18M$86.51M$58.25M$656.59M$-18.48M$120.41M$197.62M
Surprise %------------0.54%--0.37%1.07%0.83%1.27%0.99%1.02%1.19%1.06%0.82%3.65%-10.08%1.17%2.27%-0.40%0.71%

Nutrien's average Quarter net income forecast for Mar 24 is $1.69B, with a range of $1.35B to $2.02B. NTR's average Quarter net income forecast represents a 880.06% increase compared to the company's last Quarter net income of $172.00M (Dec 23).

Nutrien SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111363336105548889999999955
SG&A------------$1.04B--$930.00M$970.00M$1.00B$1.10B$988.00M$1.08B$923.00M$1.02B$799.00M$909.00M$812.00M$876.00M$714.00M$796.00M$683.00M
Avg Forecast$731.04M$696.51M$1.37B$704.55M$745.98M$733.37M$1.41B$718.04M$702.73M$744.86M$1.51B$1.21B$766.67M$798.86M$1.55B$1.10B$931.70M$1.14B$1.96B$998.86M$863.38M$722.34M$1.29B$976.56M$474.61M$501.36M$1.11B$314.16M$463.92M$539.06M
High Forecast$755.32M$719.64M$1.42B$727.96M$770.76M$757.73M$1.46B$719.39M$737.67M$769.61M$1.56B$1.45B$798.86M$867.67M$1.60B$1.32B$1.12B$1.14B$1.96B$1.20B$863.38M$722.34M$1.29B$1.17B$474.61M$501.36M$1.11B$376.99M$463.92M$539.06M
Low Forecast$700.35M$667.26M$1.31B$674.97M$714.66M$702.58M$1.35B$715.34M$674.52M$713.59M$1.45B$966.89M$734.48M$752.81M$1.48B$878.99M$745.36M$1.14B$1.96B$799.09M$863.38M$722.34M$1.29B$781.24M$474.61M$501.36M$1.11B$251.33M$463.92M$539.06M
Surprise %------------1.36%--0.85%1.04%0.88%0.56%0.99%1.25%1.28%0.79%0.82%1.92%1.62%0.79%2.27%1.72%1.27%

Nutrien's average Quarter SG&A projection for Mar 24 is $1.21B, based on 3 Wall Street analysts, with a range of $966.89M to $1.45B. The forecast indicates a 15.87% rise compared to NTR last annual SG&A of $1.04B (Dec 23).

Nutrien EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts1111111363336105548889999999955
EPS------------$0.36--$1.14$2.15$2.95$6.53$2.49$2.12$1.26$1.94$0.22$0.55$-1.03$1.34$-0.06$-0.08$0.25
Avg Forecast$0.47$0.36$2.06$0.45$0.65$0.54$2.15$0.34$0.37$0.46$2.19$0.38$0.64$0.61$2.76$1.48$2.54$3.85$5.71$2.76$2.38$1.22$2.11$0.08$0.17$0.12$1.33$-0.04$0.24$0.40
High Forecast$0.49$0.37$2.15$0.47$0.68$0.56$2.25$0.36$0.47$0.48$2.20$0.38$0.89$0.89$2.88$1.50$2.65$3.85$5.71$2.76$2.38$1.23$2.11$0.08$0.17$0.12$1.33$-0.04$0.24$0.40
Low Forecast$0.44$0.34$1.95$0.42$0.61$0.51$2.04$0.32$0.27$0.44$2.18$0.38$0.43$0.44$2.61$1.45$2.40$3.85$5.71$2.76$2.38$1.20$2.11$0.08$0.17$0.12$1.33$-0.04$0.24$0.40
Surprise %------------0.56%--0.77%0.85%0.77%1.14%0.90%0.89%1.04%0.92%2.65%3.15%-8.75%1.01%1.48%-0.34%0.63%

According to 3 Wall Street analysts, Nutrien's projected average Quarter EPS for Mar 24 is $0.38, with a low estimate of $0.38 and a high estimate of $0.38. This represents a 6.11% increase compared to NTR previous annual EPS of $0.36 (Dec 23).

Nutrien Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
AVDAmerican Vanguard$4.59$20.00335.73%Buy
ICLICL Group$4.97$7.0742.25%Hold
FMCFMC$51.70$69.5034.43%Buy
MOSMosaic Company$25.44$34.1734.32%Buy
IPIIntrepid Potash$23.82$31.5032.24%Hold
NTRNutrien$46.38$57.7124.43%Buy
CTVACorteva$58.57$66.8014.05%Buy
SMGScotts Miracle-Gro Company$72.40$81.0011.88%Hold
CFCF Industries$86.68$87.000.37%Buy

NTR Forecast FAQ

Is Nutrien a good buy?

Yes, according to 18 Wall Street analysts, Nutrien (NTR) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 50.00% of NTR's total ratings.

What is NTR's price target?

Nutrien (NTR) average price target is $57.71 with a range of $50 to $75, implying a 29.45% from its last price of $44.58. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Nutrien stock go up soon?

According to Wall Street analysts' prediction for NTR stock, the company can go up by 29.45% (from the last price of $44.58 to the average price target of $57.71), up by 68.24% based on the highest stock price target, and up by 12.16% based on the lowest stock price target.

Can Nutrien stock reach $70?

NTR's highest twelve months analyst stock price target of $75 supports the claim that Nutrien can reach $70 in the near future.

What is Nutrien's current price target trend?

1 Wall Street analyst forecast a $50 price target for Nutrien (NTR) this month, up 12.16% from its last price of $44.58. Compared to the last 3 and 12 months, the average price target increased by 12.16% and increased by 40.49%, respectively.

What are Nutrien's analysts' financial forecasts?

Nutrien's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $25.81B (high $26.5B, low $24.92B), average EBITDA is $5.43B (high $5.58B, low $5.24B), average net income is $1.82B (high $1.9B, low $1.72B), average SG&A $3.61B (high $3.7B, low $3.48B), and average EPS is $3.68 (high $3.84, low $3.47). NTR's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $25.06B (high $25.89B, low $24.01B), average EBITDA is $5.27B (high $5.45B, low $5.05B), average net income is $1.65B (high $1.72B, low $1.56B), average SG&A $3.5B (high $3.62B, low $3.35B), and average EPS is $3.33 (high $3.48, low $3.15).

Did the NTR's actual financial results beat the analysts' financial forecasts?

Based on Nutrien's last annual report (Dec 2022), the company's revenue was $37.88B, which missed the average analysts forecast of $38.27B by -1.01%. Apple's EBITDA was $12.07B, beating the average prediction of $9.79B by 23.22%. The company's net income was $7.66B, beating the average estimation of $7.17B by 6.90%. Apple's SG&A was $4.07B, missing the average forecast of $5.03B by -19.03%. Lastly, the company's EPS was $13.45, missing the average prediction of $14.87 by -9.52%. In terms of the last quarterly report (Dec 2023), Nutrien's revenue was $5.82B, beating the average analysts' forecast of $5.49B by 6.10%. The company's EBITDA was $1.27B, beating the average prediction of $1.15B by 10.33%. Nutrien's net income was $172M, missing the average estimation of $318.67M by -46.03%. The company's SG&A was $1.04B, beating the average forecast of $766.67M by 36.05%. Lastly, the company's EPS was $0.36, missing the average prediction of $0.644 by -44.10%